CAFomics: convergence to translation for precision stroma approaches

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Pancreatic ductal adenocarcinoma (PDAC) exhibits a dense, desmoplastic tumor microenvironment.
• High stromal density was previously thought to be protective, but clinical trials altering stroma have yielded disappointing results.
• Increasing evidence highlights significant heterogeneity within cancer-associated fibroblast (CAF) subpopulations.

Purpose of the Study:

• To review and harmonize current transcriptomic data on CAF subpopulations in PDAC.
• To emphasize the importance of understanding CAF and tumor microenvironment heterogeneity for therapeutic development.
• To highlight the need for improved model systems that accurately reflect PDAC's clinical behavior.

Main Methods:

• Review of existing literature on cancer-associated fibroblast (CAF) subpopulations.
• Analysis of single-cell transcriptomic studies.
• Harmonization of transcriptomic data from various CAF studies.

Main Results:

• Significant heterogeneity exists within CAF populations, challenging earlier assumptions.
• Transcriptomic data reveals distinct CAF subpopulations.
• Understanding this heterogeneity is crucial for developing targeted therapies.

Conclusions:

• Understanding CAF heterogeneity and other tumor microenvironment features is critical for effective PDAC therapeutic strategies.
• Identifying clinically relevant CAF subtypes requires examining subpopulations defined by clinical outcomes.
• The future of precision oncology in PDAC necessitates integrating precision approaches for both tumor epithelium and stroma.